Assessment of Thyroid Doppler Ultrasound in Followup of Pediatric Graves' Disease
1 other identifier
observational
32
0 countries
N/A
Brief Summary
All cases of the study will be diagnosed as Graves' by History, examination, laboratory (FT3, FT4, TSH \& TRAbs), X-ray on left wrist for bone age, neck grey scale ultrasonography for thyroid gland size, shape, echotexture, vascularity and nodule characters if present with TIRAD score calculation. Then Color flow doppler ultrasound will be done to asses thyroid volume, number of vessels per square cm and inferior thyroid artery peak systolic velocity, end diastolic velocity and resistive index. Patients then will receive carbimazole antithyroid drug at dose 0.25-0.5 mg/kg/day PO \& the dose will be titrated according to thyroid function test after 4-6 weeks. Beta-adrenergic blockade will be added to all symptomatic cases. Regular follow up will be done every month of first 3 months of diagnosis and then every 3 months for 2 years by clinical and thyroid function test to asses response, compliance, complications, drug side effects, remission and relapses. Doppler ultrasound will be done at 0, 12 and 24 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2024
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 5, 2024
CompletedFirst Posted
Study publicly available on registry
April 10, 2024
CompletedStudy Start
First participant enrolled
August 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 5, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 5, 2028
July 16, 2024
July 1, 2024
2.7 years
April 5, 2024
July 14, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
thyroid volume
3 years
number of vessels per square cm of thyroid gland
2 years
inferior thyroid artery peak systolic velocity
2 years
end diastolic velocity
2 years
resistive index
2 years
Eligibility Criteria
children who will come at pediatric endocrinology outpatient clinic of Assiut University Children's Hospital meeting our inclusion criteria.
You may qualify if:
- All newly diagnosed children with clinical and laboratory hyperthyroidism (high T4 \& low TSH) with positive TRAbs.
You may not qualify if:
- Patients receiving radioiodine Patients underwent thyroid surgery History of neck radiation or neck surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant lecturer of pediatrics
Study Record Dates
First Submitted
April 5, 2024
First Posted
April 10, 2024
Study Start
August 5, 2024
Primary Completion (Estimated)
April 5, 2027
Study Completion (Estimated)
April 5, 2028
Last Updated
July 16, 2024
Record last verified: 2024-07